Lexicon Pharmaceuticals, Inc.’s LXRX share price has dipped by 11.08%, which has investors questioning if this is right time ...

Q1 2025 Earnings Call Transcript May 13, 2025 Lexicon Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is ...

Analysts have given Lexicon Pharmaceuticals a total of 5 ratings, with the consensus rating being Buy. The average one-year ...

On a per-share basis, the The Woodlands, Texas-based company said it had a loss of 7 cents. The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks ...

Lexicon Pharmaceuticals (NASDAQ:LXRX) is gearing up to announce its quarterly earnings on Tuesday, 2025-05-13. Here's a quick overview of what investors should know before the release. Analysts ...

THE WOODLANDS, Texas, May 06, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in a fireside chat at the 3rd Annual H ...

Lexicon Pharmaceuticals (NASDAQ:LXRX) is scheduled to announce Q1 earnings results on Tuesday, May 13th, after market close. The consensus EPS Estimate is -$0.10 and the consensus Revenue Estimate is ...

(MENAFN- GlobeNewsWire - Nasdaq) THE WOODLANDS, Texas, May 06, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in a ...